Lead Moderators
    • Internal Medicine
    • Hematology and Oncology
    • Lymphoma
    • Venous Thromboembolism
    • Myeloma
    • Leukemia
    Dr. Dittus is currently a chief hematology-oncology fellow at Boston University Medical Center. Prior to his fellowship training, he completed his residency and chief residency in internal medicine at Lenox Hill Hospital, North Shore-LIJ Health System in New York City. His clinical interests include the evaluation and treatment of leukemia, lymphoma, and myeloma. Additionally, Dr. Dittus has an interest in cancer-associated venous thromboembolism (VTE), and the evolving role for the direct oral anticoagulants in preventing and treating VTE in this population. He is currently serving as a sub-investigator on a clinical trial evaluating the use of rivaroxaban prophylaxis in ambulatory cancer patients at high risk for venous thromboembolism. Dr. Dittus has written two book chapters on venous thromboembolism prevention and treatment, as well as two review articles on the use of the new oral anticoagulants.